ISO TS 5798-2022 PDF

ISO TS 5798-2022 PDF

In Vitro Diagnostic Test Systems-Requirements And Recommendations For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) By Nucleic Acid Amplification Methods

$129.00 $258.00 -50%
Product Code: ISO TS 5798
Stock In Stock
Edition: 1ST
Published: 04/2022
Number of Pages: 52
File Size: 1 file, 3 Bytes

Available Options

Product Description

In Vitro Diagnostic Test Systems — Requirements And Recommendations For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) By Nucleic Acid Amplification Methods

Introduction: Coronaviruses are enveloped RNA viruses that are broadly distributed in the animal kingdom. They have been identified in humans, other mammals, and birds. Coronaviruses were named because the spike proteins known to facilitate viral attachment and cell entry appear like a halo on the virus surface when viewed under an electron microscope. Coronaviruses are roughly spherical with a diameter ranging from 118 nm to 136 nm. The coronavirus genome, which ranges from 26 kb to 32 kb, is the largest among all RNA viruses, including RNA viruses that have segmented genomes. Until 2019, six coronaviruses have been associated with human diseases: — severe acute respiratory syndrome-related coronavirus (SARS-CoV), — Middle East respiratory syndrome coronavirus (MERS-CoV), — human coronavirus 229E (HCoV-229E), — human coronavirus OC43 (HCoV-OC43), — human coronavirus NL63 (HCoV-NL63), and — human coronavirus HKU1 (HCoV-HKU1)[1]. In 2019, a cluster of patients presenting with a respiratory disease were shown, by sequencing, to be infected with a novel coronavirus[2]. The coronavirus associated with this cluster was subsequently named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses[3]. SARS-CoV-2 is the seventh coronavirus known to infect humans. The disease caused by SARS-CoV-2 was designated as coronavirus infectious disease 2019 (COVID-19) by the World Health Organization (WHO)[4]. The host range for SARS-CoV-2 is not yet

Scope: This document provides requirements and recommendations for the design, development, verification, validation and implementation of analytical tests for detecting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using nucleic acid amplification. It addresses pre-examination, examination and post-examination process steps for human specimens. This document is applicable to medical laboratories. It is also intended to be used by in vitro diagnostic developers and manufacturers, as well as by institutions and organizations supporting SARS-CoV-2 research and diagnostics. This document does not apply to environmental samples.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good
ISO TS 5798-2022 PDF

ISO TS 5798-2022 PDF

$129.00 $258.00